Patients turn to 'gray market' for cheaper obesity drugs, but it's risky

NPRTuesday, October 7, 2025 at 9:05:51 PM
NegativeHealth
Patients turn to 'gray market' for cheaper obesity drugs, but it's risky
Patients seeking more affordable obesity medications are increasingly turning to the gray market, where they purchase raw ingredients from China to prepare the drugs themselves. This trend raises significant concerns about safety and efficacy, as these unregulated sources can pose serious health risks. It's crucial for patients to understand the potential dangers involved in this approach, as the lack of oversight may lead to harmful consequences.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Hospitals knew a heart device led to more patients' deaths - but they kept using it
NegativeHealth
Hospitals continued to use a heart pump device despite knowing it was linked to a significant increase in patient deaths. Reports indicate that almost half of the patients who received the device died shortly after its implantation, raising serious ethical concerns about patient safety and medical practices. The NHS had previously expressed concerns regarding the device, yet hospitals persisted in its use, highlighting a troubling disregard for patient welfare in favor of continuing established medical practices. This situation underscores the need for stricter oversight and accountability in medical device usage to protect patients.